Analyst Ratings for Alpha Tau Medical Ltd. (DRTS)
DRTS Rating Summary
DRTS Price Target Summary
- Highest: $30.00 (Barclays)
- Lowest: $8.00 (Piper Sandler)
- Average: $15.40
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$15.40 (+2.5%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 83%
Avg. $ Target:
$15.40 (+2.5%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 83%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/28/2026 | Barclays » Updated 9/3/2026 |
Lukas Shumway | New Coverage | Overweight (N/A) |
30.00 (17.00) |
10.37 (15.03) |
44.94% | Details |
| 3/4/2026 | Piper Sandler » Updated 5/19/2026 |
Jason Bednar | Downgrade | Neutral (Overweight) |
8.00 (5.00) |
7.63 (15.03) |
96.99% | Details |
 |
||||||||
|
||||||||
|
||||||||
